SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-025666
Filing Date
2022-09-13
Accepted
2022-09-12 18:25:16
Documents
76
Period of Report
2022-07-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1378936
2 ex10-1.htm EX-10.1 23467
3 ex31-1.htm EX-31.1 19522
4 ex31-2.htm EX-31.2 19510
5 ex32-1.htm EX-32.1 7535
6 ex32-2.htm EX-32.2 7566
  Complete submission text file 0001493152-22-025666.txt   6842246

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE adxs-20220731.xsd EX-101.SCH 41970
8 XBRL CALCULATION FILE adxs-20220731_cal.xml EX-101.CAL 63251
9 XBRL DEFINITION FILE adxs-20220731_def.xml EX-101.DEF 154256
10 XBRL LABEL FILE adxs-20220731_lab.xml EX-101.LAB 331524
11 XBRL PRESENTATION FILE adxs-20220731_pre.xml EX-101.PRE 267726
70 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1511428
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 221239461
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences